EGRX

Eagle Pharmaceuticals Inc
31.76
-1.75 (-5.22%)
Company Name Stock Ticker Symbol Market Type
Eagle Pharmaceuticals Inc EGRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.75 -5.22% 31.76 20:00:00
Open Price Low Price High Price Close Price Prev Close
33.28 31.605 33.50 31.76 33.51
more quote information »

Recent News

Date Time Source Heading
2/06/20239:30IHNWFeaturedHempacco Pre-launches Snoop Dogg Brands at the Champs Trade Show in Las Vegas, February 8 - 11, Exhibiting with Death Row Vapes in Booth #1201
2/06/202316:48EDGARStatement of Changes in Beneficial Ownership (4)
1/31/202318:22EDGARStatement of Changes in Beneficial Ownership (4)
1/26/202309:01EDGARAmended Statement of Ownership (sc 13g/a)
1/24/202318:14EDGARStatement of Changes in Beneficial Ownership (4)
1/20/202315:05EDGARAmended Statement of Ownership (sc 13g/a)
1/10/202316:06EDGARCurrent Report Filing (8-k)
1/10/202314:00GLOBEEagle Pharmaceuticals Provides Business Update and Guidance..
1/10/202307:37EDGARAmended Current Report Filing (8-k/a)
1/09/202317:03EDGARCurrent Report Filing (8-k)
1/09/202316:35EDGARStatement of Changes in Beneficial Ownership (4)
1/09/202316:34EDGARStatement of Changes in Beneficial Ownership (4)
12/21/202216:30GLOBEEagle Pharmaceuticals to Present at the 41st Annual J.P...
12/19/202207:34DJNEagle Pharmaceuticals Gets FDA Approval for New Pemfexy..
12/19/202206:50GLOBEEagle Pharmaceuticals Receives FDA Approval for Additional..
12/14/202217:23EDGARCurrent Report Filing (8-k)
12/12/202207:04EDGARCurrent Report Filing (8-k)
12/12/202206:50GLOBEEagle Pharmaceuticals Reaches Settlement Agreement with..
12/09/202217:14EDGARCurrent Report Filing (8-k)
12/06/202207:34EDGARCurrent Report Filing (8-k)
12/01/202206:50GLOBEEagle Pharmaceuticals’ Investor Day to Focus on Acute Care..
11/16/202206:50GLOBEEagle Pharmaceuticals’ Investor Day to Feature..
11/14/202206:50GLOBEEagle Pharmaceuticals Announces FDA Acceptance of..
11/09/202217:25EDGARQuarterly Report (10-q)
11/09/202206:58EDGARAmended Current Report Filing (8-k/a)
11/09/202206:50GLOBECorrecting & Replacing: Eagle Pharmaceuticals Reports Third..
11/07/202206:57EDGARCurrent Report Filing (8-k)
11/07/202206:50GLOBEEagle Pharmaceuticals Reports Third Quarter 2022 Results
11/03/202206:05EDGARCurrent Report Filing (8-k)
10/31/202206:50GLOBEEagle Pharmaceuticals to Host Third Quarter 2022 Financial..
10/20/202206:03EDGARNotice of Effectiveness (effect)
10/19/202216:39GLOBESAVE THE DATE: Eagle Pharmaceuticals to Host Investor Day on..
10/12/202206:50GLOBEEagle Pharmaceuticals Announces Submission of..
10/03/202207:54DJNEagle Pharmaceuticals Gets FDA Designation for Infant Apnea..
10/03/202206:55EDGARCurrent Report Filing (8-k)
10/03/202206:50GLOBEEagle Pharmaceuticals and Enalare Therapeutics Announce FDA..
9/27/202207:01EDGARCurrent Report Filing (8-k)
9/27/202206:50GLOBEEagle Pharmaceuticals and Enalare Therapeutics Announce..
9/08/202217:10EDGARStatement of Changes in Beneficial Ownership (4)
8/30/202216:05GLOBEEagle Pharmaceuticals to Present at the Morgan Stanley 20th..
8/18/202212:53GLOBEFederal Circuit Rules in Favor of Eagle Pharmaceuticals in..
8/09/202217:29EDGARQuarterly Report (10-q)
8/09/202208:28EDGARCurrent Report Filing (8-k)
8/09/202206:50GLOBEEagle Pharmaceuticals Reports Second Quarter 2022 Results
8/09/202206:45GLOBEEagle Pharmaceuticals Takes Equity Stake in, with Option to..
8/04/202208:12EDGARAmended Current Report Filing (8-k/a)
8/01/202208:32EDGARCurrent Report Filing (8-k)
7/28/202216:05GLOBEEagle Pharmaceuticals to Host Second Quarter 2022 Financial..
7/18/202216:06EDGARCurrent Report Filing (8-k)
7/18/202206:57EDGARCurrent Report Filing (8-k)
7/18/202206:50GLOBEEagle Pharmaceuticals Appoints Debra M. Hussain as SVP, Head..